Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes
Hematol., Transfus. Cell Ther. (Impr.)
;
45(1): 98-101, Jan.-Mar. 2023. graf, ilus
Article
in English
| LILACS
| ID: biblio-1421558
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Hemophilia A
Type of study:
Health economic evaluation
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
Hematol., Transfus. Cell Ther. (Impr.)
Journal subject:
Hematologia
/
TransfusÆo de Sangue
Year:
2023
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Centro de Hematologia e Hemoterapia do Rio Grande do Norte/BR
/
Universidade Federal de Minas Gerais - UFMG/BR
Similar
MEDLINE
...
LILACS
LIS